Abstracts

Exposure to PrEP and Safety Monitoring in Pregnancy: Importance of Objective Exposure Measurement

Background: To date, TDF/FTC for pre-exposure prophylaxis (PrEP) safety in pregnancy has been based on self-reported adherence or study allocation with no safety studies using objective exposure measures. Methods: The PrEP in pregnancy and postpartum (PrEP-PP) study in Cape Town enrolled pregnant women =>16 years without HIV at their first antenatal care visit followed-up through…

Clinical Relevance of the CRAG Semiquantitative Scores in CRAG-Positive People with AIDS

Background: High cryptococcal antigen (CrAg) titer is associated with higher mortality in patients with cryptococcal meningitis and in asymptomatic CrAg-positive people in Africa. CrAg titer testing may improve patient management; however, titer testing is cumbersome and expensive. Here, we evaluate the diagnostic performance of IMMY CrAg semiquantitative (CrAg SQ) LFA and determine the association of…

In-Hospital Mortality During Different SARS-CoV-2 Variant Waves in the EuCARE Multinational Cohort

Background: Investigating outcomes of patients hospitalized with COVID-19 throughout the pandemic is crucial to understand the effects of SARS-CoV-2 variants, previous immunity, and healthcare interventions. We compared 28-day in-hospital mortality in adults hospitalized with COVID-19 caused by Wild-type, Alpha, Delta, or Omicron variants. Whether the difference in risk by variant might vary by age was…

Pharmacogenetic Associations With HIV-1 Virologic Suppression Among Patients with TB/HIV in Brazil

Background: Human genetic variants can affect TB and HIV drug pharmacokinetics (PK), which may affect risk for toxicity or treatment failure. Here we evaluated associations between pre-specified genetic variants and HIV virologic suppression (VS) among patients treated for TB and HIV. Methods: We included TB/HIV RePORT-Brazil participants who initiated standard TB treatment [2 months of…

Predictors of Breakthrough COVID-19 Infection From the STOPCoV Cohort

Background: Our current understanding of the human immune response to SARS-CoV-2 does not enable us to quantify the degree of protection COVID-19 vaccines confer against infection and transmission especially with emerging variants. Methods: The STOPCoV (Safety and effectiveness of Preventative COVID Vaccines) study is an ongoing prospective decentralized study with the primary aim of comparison…

Effects of HIV Status on Incidence of Post-COVID Conditions in Patients With SARS-CoV-2 (COVID-19)

Background: SARS-CoV-2 (COVID) has been linked to long-term effects known as Post-COVID Conditions (PCC), that present post-acute COVID infection. While many studies have estimated PCC incidence, few have focused on immunocompromised patients, such as people with HIV (PWH). We estimated PCC incidence among PWH compared with people without HIV (PWoH) within Kaiser Permanente Mid-Atlantic States…

Clonal Hematopoiesis and HIV Infection Are Associated With Geriatric Outcomes: The ARCHIVE Study

Background: People living with HIV have accelerated biological aging and a higher prevalence of aging-related comorbidities and geriatric outcomes. Clonal hematopoiesis (CH), an aging-related cellular phenomenon that is linked to adverse clinical outcomes, is increased in people living with HIV. Here we evaluated geriatric outcomes in older adults with and without HIV to determine whether…